Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03307031
Other study ID # 1.990.955
Secondary ID
Status Completed
Phase N/A
First received September 13, 2017
Last updated October 5, 2017
Start date March 1, 2017
Est. completion date September 13, 2017

Study information

Verified date August 2017
Source Federal University of Rio Grande do Sul
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the present study was to assess the influence of different volumes of Pilates training exercises on metabolic, blood pressure (BP), functional physical fitness (PF) and quality of life (QL) outcomes in postmenopausal dyslipidemic women. In total, 26 women participated in the controlled clinical trial, being allocated into three groups: high volume group (HVG; n=9), low volume group (LVG; n=11) and control group (CG, n=6). HVG performed four weekly sessions and LVG performed only twice a week, during 10 weeks with 45 to 55 minutes per session. Before and after the intervention period, metabolic, BP, PF, QL and cardiovascular risk score (CRS) outcomes were measured. The results were described by mean values with lower and upper limits (95% confidence interval). Comparisons between groups and intra-groups were performed adopting Generalized Estimating Equations (GEE) method, with post hoc of Bonferroni and significance level of ɑ=0,05.


Recruitment information / eligibility

Status Completed
Enrollment 26
Est. completion date September 13, 2017
Est. primary completion date July 28, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 60 Years to 75 Years
Eligibility Inclusion Criteria:

- Dyslipidemic, postmenopausal and sedentary.

Exclusion Criteria:

- Women taking statins and smokers.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
High Volume Group
Performed four weekly session, during 10 weeks with 45 to 55 minutes per session.
Low Volume Group
Performed only twice a week, during 10 weeks with 45 to 55 minutes per session.
Control Group
Did not exercise, during 10 weeks.

Locations

Country Name City State
Brazil Adriana Cristine Koch Buttelli Porto Alegre Rio Grande do Sul

Sponsors (1)

Lead Sponsor Collaborator
Federal University of Rio Grande do Sul

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Metabolic outcomes Cholesterol (mg/dl) 10 weeks
Primary Metabolic outcomes Low-density lipoprotein (mg/dl) 10 weeks
Primary Metabolic outcomes Triglycerides (mg/dl) 10 weeks
Primary Metabolic outcomes High-density lipoprotein (mg/dl) 10 weeks
Primary Metabolic outcomes TC/HDL ratio 10 weeks
Secondary Secondary outcomes Systolic blood pressure (mmHg) 10 weeks
Secondary Secondary outcomes Diastolic blood pressure (mmHg) 10 weeks
Secondary Secondary outcomes Functional physical fitness 10 weeks
Secondary Secondary outcomes Quality of life 10 weeks
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Completed NCT04894318 - The Effect Of Low-Fat And Low-Cholesterol Dietary Intervention On LDL Sub-Groups In Turkısh Dyslipidemic Patients N/A
Completed NCT04862962 - Study to Evaluate the Safety of the Fixed-dose Combination Rosuvastatin/Ezetimibe for Patients With Dyslipidaemia
Completed NCT04052594 - A Study of LY3475766 in Healthy Participants Phase 1
Active, not recruiting NCT04270084 - Metabolic Optimization Through Diet/Lifestyle Improvements For Youth N/A
Completed NCT03241121 - Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome N/A
Completed NCT04516291 - A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70) Phase 2
Completed NCT03170752 - Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A
Completed NCT04186780 - Effects of Lentinula Edodes Bars on Dyslipidemia and Oxidative Stress in Cholesterol Individuals: Randomized Study N/A
Not yet recruiting NCT03674333 - Effect of Adding Folic Acid on Lipid Parameters in Population With Dyslipidemias N/A
Not yet recruiting NCT06159543 - The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes N/A
Terminated NCT01697735 - The Therapeutic Effects of Statins and Berberine on the Hyperlipemia Phase 4
Completed NCT00362908 - Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic Syndrome N/A
Completed NCT00455325 - Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS) Phase 2
Completed NCT00644709 - A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD) Phase 4
Recruiting NCT05624658 - Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS N/A
Recruiting NCT03988101 - Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event Phase 4
Recruiting NCT06024291 - Reducing Circulating Sphingolipid Levels to Optimise Cardiometabolic Health - The SphingoFIT Trial N/A
Completed NCT01218204 - A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin Phase 2